deltatrials
Completed PHASE2 INTERVENTIONAL 2-arm NCT02562482

Trial for Safety and Immunogenicity of a Chikungunya Vaccine, VRC-CHKVLP059-00-VP, in Healthy Adults

Phase 2 Randomized, Placebo-Controlled Trial to Evaluate the Safety and Immunogenicity of a Chikungunya Virus-Like Particle Vaccine, VRC-CHKVLP059-00-VP, in Healthy Adults

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Conditions Chikungunya Virus Infection
Interventions VRC-CHKVLP059-00-VP VRC-PBSPLA043-00-VP
Updated 13 times since 2017 Last updated: Oct 20, 2020 Started: Nov 18, 2015 Primary completion: Mar 6, 2018 Completion: Mar 6, 2018
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02562482, this PHASE2 trial focuses on Chikungunya Virus Infection and remains completed. Sponsored by National Institute of Allergy and Infectious Diseases (NIAID), it has been updated 13 times since 2015, reflecting substantial change activity. This study is part of the global effort to build evidence for infectious disease interventions.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshot~Feb 2017 – ~Jun 2018 · 16 months · monthly snapshot~Jun 2018 – ~Jul 2018 · 30 days · monthly snapshot~Jul 2018 – ~Jun 2019 · 11 months · monthly snapshot~Jun 2019 – ~Mar 2020 · 9 months · monthly snapshot~Mar 2020 – ~Jul 2020 · 4 months · monthly snapshot~Jul 2020 – ~Nov 2020 · 4 months · monthly snapshot~Nov 2020 – ~Jan 2021 · 2 months · monthly snapshot~Jan 2021 – ~Dec 2021 · 11 months · monthly snapshot~Dec 2021 – ~Jul 2024 · 31 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshot~Sep 2025 – present · 10 months · monthly snapshot

Change History

13 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed PHASE2

  2. Sep 2024 — Sep 2025 [monthly]

    Completed PHASE2

  3. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2

  4. Dec 2021 — Jul 2024 [monthly]

    Completed PHASE2

  5. Jan 2021 — Dec 2021 [monthly]

    Completed PHASE2

▶ Show 8 earlier versions

  1. Nov 2020 — Jan 2021 [monthly]

    Completed PHASE2

  2. Jul 2020 — Nov 2020 [monthly]

    Completed PHASE2

  3. Mar 2020 — Jul 2020 [monthly]

    Completed PHASE2

  4. Jun 2019 — Mar 2020 [monthly]

    Completed PHASE2

    Status: Active Not Recruiting → Completed

  5. Jul 2018 — Jun 2019 [monthly]

    Active Not Recruiting PHASE2

  6. Jun 2018 — Jul 2018 [monthly]

    Active Not Recruiting PHASE2

  7. Feb 2017 — Jun 2018 [monthly]

    Active Not Recruiting PHASE2

  8. Jan 2017 — Feb 2017 [monthly]

    Active Not Recruiting PHASE2

    First recorded

Nov 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • National Institute of Allergy and Infectious Diseases (NIAID)
Data source: National Institute of Allergy and Infectious Diseases (NIAID)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations